Diabetes Care Transformation: Diabetes Data Registry and Intensive Remote Monitoring (DCT1A)
Type 1 Diabetes Mellitus
About this trial
This is an interventional treatment trial for Type 1 Diabetes Mellitus
Eligibility Criteria
Inclusion Criteria:
- Type 1 diabetes, using an insulin pump (Medtronic, Omnipod, Animas)
- Duration of diabetes >1 year
- Age: 8-17 years of age, inclusive.
- Hemoglobin A1c 8.0-10.0% at baseline visit, inclusive.
- Seen in the McNeely Diabetes Clinic within the past 6 months.
- The family/child is testing blood glucose at least 4 times a day.
- The family has a smart phone and service.
Exclusion Criteria:
- The child is not using insulin for management of diabetes.
- The child uses multiple daily injections of insulin.
- The child is unwilling to use the wearable device, or the family is unwilling or unable to upload glucose and insulin data on a routine basis
- The family is unwilling or unable to upload data from devices such as meter, pump, sensor, wearable device.
- Diagnosis of a mental health disorder.
- Parent/child does not speak English as the device software is only available in English.
Sites / Locations
- Children's Hospitals and Clinics of Minnesota
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Data Upload
Weekly Review
Subjects will wear a FitBit activity monitor and continue to use their insulin pump. FitBit, pump and sensor (if applicable) data will be uploaded at least weekly. Subjects will continue to receive usual diabetes care. Phone calls and emails to the diabetes clinic will be initiated by the family.
Subjects will wear a FitBit activity monitor and continue to use their insulin pump. FitBit, pump and sensor (if applicable) data will be uploaded at least weekly. For subjects in the weekly review group, research staff (diabetes educator, nurse practitioner and/or physician) will review uploaded blood glucose, pump, and available sensor, activity and sleep data on a weekly basis. If glucose patterns are identified which suggest a change to diabetes management (ie insulin dose changes), the family will be contacted by text, email or telephone to review glucose patterns and to review staff recommendations.